Free
Meeting Abstracts  |   July 2006
Antagonistic Actions of Halothane and Sevoflurane on Spontaneous Ca2+Release in Rat Ventricular Myocytes
Author Affiliations & Notes
  • Mark D. Graham, B.Sc.
    *
  • Philip M. Hopkins, M.D.
  • Simon M. Harrison, Ph.D.
  • * Research Student, ‡ Senior Lecturer, Institute of Membrane and Systems Biology, Faculty of Biological Sciences, † Professor of Anaesthesia, Academic Unit of Anaesthesia, University of Leeds.
Article Information
Meeting Abstracts   |   July 2006
Antagonistic Actions of Halothane and Sevoflurane on Spontaneous Ca2+Release in Rat Ventricular Myocytes
Anesthesiology 7 2006, Vol.105, 58-64. doi:
Anesthesiology 7 2006, Vol.105, 58-64. doi:
HALOTHANE and sevoflurane have been reported to induce both positive and negative inotropic effects in isolated ventricular myocytes when these agents are either applied or removed, the mechanisms of which are not fully elucidated. For example, application of halothane induces an initial positive inotropic effect1–6 thought to result from sensitization of the sarcoplasmic reticulum (SR) Ca2+release process,3,4,7,8 followed by a sustained negative inotropic effect due primarily to reductions in SR Ca2+content,3,4,9,10 the L-type Ca2+current (ICa),1,11–15 and myofilament Ca2+sensitivity.4,6,16,17 In contrast, sevoflurane initially depresses contractility, which then recovers toward control during the exposure,5,6,18 and on removal, a short-lived positive inotropic effect is induced5,6,18 before contractions return to control values. In cells equilibrated with ryanodine to inhibit SR function, the initial positive inotropic effect of halothane is blocked, the extent of initial inhibition of contraction on exposure to sevoflurane is reduced, and the magnitude of the positive inotropic effect on removal is greatly diminished, suggesting a pivotal role of SR Ca2+regulation in these inotropic effects.5 The aim of this study was to investigate whether halothane, isoflurane, and sevoflurane affected the sensitivity of the SR Ca2+release process. To assess this function, we used unstimulated single ventricular myocytes in which mild Ca2+overload was induced by increase of extracellular Ca2+.19,20 This leads to the induction of spontaneous Ca2+transients, which are reproducible in their frequency and amplitude. It has been shown previously that these spontaneous Ca2+transients reflect Ca2+release from the SR as they are abolished by ryanodine.4 Using this model, changes in the frequency and/or amplitude of spontaneous Ca2+transients in the presence of the anesthetics will provide evidence for the contribution of the sensitivity of the SR Ca2+release process to the inotropic profiles of these anesthetics.
Materials and Methods
These studies conformed to the Guide for the Care and Use of Laboratory Animals  ,21 and all animal procedures conformed to schedule 1 regulations described in the Animals (Scientific Procedures) Act, 1986, of the United Kingdom government Home Office. Rat ventricular myocytes were prepared as described previously.6 
Recording Cytosolic Ca2+
Freshly dissociated cells were loaded with fura-2 by gentle agitation of a 2-ml aliquot of cell suspension with 6.25 μl fura-2 AM, 1 mm, in dimethyl sulfoxide for 12 min followed by centrifugation and resuspension in the physiologic salt solution (see Solutions, first sentence). Cells were transferred to a tissue chamber (volume, 0.1 ml) attached to the stage of an inverted microscope (Nikon Diaphot; Nikon, Surrey, United Kingdom) and allowed to settle for several minutes onto the glass bottom of the chamber before being superfused at a rate of approximately 3 ml/min with the physiologic salt solution. Solutions were delivered to the experimental chamber by magnetic drive gear metering pumps (Micropump, Concord, CA), and solution level and temperature were maintained by feedback circuits.22 All experiments were conducted at 30°C to maximize the retention of cytosolic fura-2. To record Ca2+transients, the fura-2–loaded cells were excited alternately with light at 340 and 380 nm using a monochromator based system (Cairn; Faversham, Kent, United Kingdom) and fluorescence detected at 510 nm. The ratio of fluorescence at 510 nm in response to excitation at 340 and 380 nm was used as a measure of the intracellular Ca2+concentration. Ca2+transients were digitized at 1 kHz and analyzed using Ionoptix software (Milton, MA).
Solutions
During experimentation, cells were perfused with the following physiologic salt solution: 140 mm NaCl, 5.4 mm KCl, 1.2 mm MgCl2, 0.4 mm NaH2PO4, 5 mm HEPES, 10 mm glucose, and 1 or 2 mm CaCl2, pH 7.4 (NaOH) at 30°C. Halothane, isoflurane, and sevoflurane were delivered from stock solutions made up in dimethyl sulfoxide; the final concentration of dimethyl sulfoxide never exceeded 0.2%, which had no significant effect on Ca2+transients (not shown). The maximum final bath concentration of anesthetic used in the experiments, 0.6 mm, approximates to twice the minimum alveolar concentration of halothane, isoflurane, and sevoflurane, and therefore, these concentrations are both clinically relevant and broadly equianesthetic in rat ventricle.23 Concentrations of anesthetics in the superfusate were verified with gas–liquid chromatography4 and found to be stable over the course of an experiment.
Experimental Protocol
When cells were perfused with solution containing increased (2 mm) Ca2+, spontaneous Ca2+transients were evoked, which propagated down the cells as Ca2+waves. The frequency and amplitude of these transients were recorded in the absence of anesthetic to establish baseline conditions. If frequency or amplitude was not regular over a period of at least 2 min, the cell was discarded. When steady baseline conditions were achieved, the cells were exposed to 0.6 mm of halothane, isoflurane, or sevoflurane (or a mixture of anesthetics with a total anesthetic concentration of 0.6 mm) for a period of 4 min before control perfusate was restored. The frequency and amplitude of spontaneous Ca2+transients were recorded during periods of 30 s. For purposes of analysis of Ca2+transient amplitude, if a cell did not display any spontaneous transients during a 30-s period (e.g.  , see fig. 1A), that cell was not included in the calculation of mean amplitude for that time period because this would artificially reduce amplitude of transients in cells where they did occur. However, to give a more complete picture of total SR Ca2+release, data are also presented as the product of frequency and amplitude. In these experiments, each cell acted as its own control and was only exposed to one anesthetic (or one anesthetic mixture) except for the protocols in electrically stimulated cells (see Discussion). In all groups of cells, there were no significant differences in either the frequency or amplitude of spontaneous Ca2+release under baseline conditions (analysis of variance).
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
×
Statistical Analysis
Data are presented as mean ± SEM, and statistical comparisons were conducted with SigmaStat, (SPSS, Chicago, IL) using one-way repeated-measures analysis of variance followed by Tukey tests for multiple comparisons or Friedman repeated-measures analysis of variance on ranks followed by Tukey tests for multiple comparison if data failed normality or equal variance tests. Independent sample t  tests were used for comparison of the effects of halothane alone versus  halothane–sevoflurane mixtures on the frequency of spontaneous Ca2+release. All figures were prepared using SigmaPlot (SPSS).
Results
Effects of Halothane, Sevoflurane, and Isoflurane on Spontaneous Ca2+Release
Figure 1Aillustrates spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. The frequency (fig. 1B) and amplitude (fig. 1C) of spontaneous Ca2+transients assessed over consecutive 30-s periods were stable over the initial control period (0–120 s). Addition of 0.6 mm halothane led to an immediate increase in frequency (from 2.6 ± 0.21 to 7.5 ± 0.5 transients per 30 s; P  < 0.05 vs.  control), which then declined to a level not significantly different from control (fig. 1B). At the end of the 4-min exposure, Ca2+transient amplitude was significantly reduced to 54 ± 10% of control (P  < 0.05). On removal of halothane, the frequency of spontaneous Ca2+release declined (P  < 0.05) for a period of 60 s before returning to control. The amplitudes of events (when they occurred, see Materials and Methods) remained below control but after 2 min of control perfusate were restored. The product of frequency and amplitude (fig. 1D), which gives a measure of total Ca2+release, reflected changes in both variables.
In contrast, sevoflurane initially reduced the frequency of spontaneous Ca2+release (P  < 0.05) over a period of 60 s (figs. 2A and B), which returned toward control levels during the 4-min exposure, with no significant change in the amplitude of spontaneous Ca2+transients (fig. 2C). On removal of sevoflurane, frequency was enhanced transiently (P  < 0.05) before returning to control, but again, this was not accompanied by any change in Ca2+transient amplitude. Figure 2Dillustrates that total Ca2+release reflected the effect of sevoflurane on frequency, not amplitude, of release.
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
×
Isoflurane (0.6 mm) had no significant effect on the frequency or amplitude of spontaneous Ca2+release when first applied, during the exposure, or on removal (not shown), suggesting that isoflurane had no net influence on the sensitivity of SR Ca2+release.7 
SR Ca2+Content at the Point of Spontaneous Release
Because spontaneous release of Ca2+from the SR is strongly dependent on SR Ca2+content,24 this was assessed by rapid application of 20 mm caffeine at the time point when the next spontaneous Ca2+release was expected. Figure 3Aillustrates this protocol; under control conditions, 20 mm caffeine was applied to the cell under study to discharge SR Ca2+content. After removal of caffeine, spontaneous Ca2+transients were restored. Anesthetic, 0.6 mm, was then applied, and the caffeine protocol was repeated at the beginning and at the end of the 4-min anesthetic exposure. Figures 3B and Cillustrate that sevoflurane significantly increased the magnitude of caffeine-induced release of Ca2+from the SR (a measure of SR Ca2+content) during the exposure (to 110 ± 12%, n = 10; P  < 0.05), as would be expected if SR Ca2+release were inhibited, whereas halothane reduced content to 77 ± 24% (n = 9; P  < 0.05), consistent with a halothane-induced enhancement of SR Ca2+release (i.e.  , spontaneous Ca2+release evoked at a lower SR Ca2+content).
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
×
Amelioration of Halothane-induced Effects by Sevoflurane
These results illustrate that halothane and sevoflurane have opposing effects on the SR Ca2+release process, in which case the effects of halothane might be ameliorated or reversed by coapplication of sevoflurane. The experiments in figure 4illustrate the results of experiments in which mixtures of halothane and sevoflurane were applied to spontaneously active cells; application of a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (fig. 4A) significantly increased frequency of release (P  < 0.05) from an average value of 1.8 (over the four 30-s control periods) to 3.1 over the first 30-s period of exposure, before returning to control (fig. 4B). This compares to 0.6 mm halothane alone (fig. 1B), where frequency increased from an average value of 2.6 (over four 30-s periods) to 7.5 (over the first 30-s period). This could result from the lower actual concentration of halothane, but this was investigated in a separate series of experiments (see next paragraph, second sentence). The mixture of 0.1 mm halothane and 0.5 mm sevoflurane (fig. 4C) effectively abolished the initial transient increase in frequency that we observed with 0.1 mm halothane alone and figure 4Dshows that during the first 30-s period, frequency of release was actually reduced. After removal of this anesthetic mixture, there was no effect on the frequency of release.
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
×
Figure 5Aillustrates that as the proportion of sevoflurane was increased in the mixture, the frequency of spontaneous events on application declined with the line crossing baseline conditions (dotted line) at approximately 0.1 mm halothane–0.5 mm sevoflurane. The effect of 0.1 and 0.3 mm halothane alone (filled symbols) on the initial increase in frequency was significantly (P  < 0.05) greater than that induced by the anesthetic mixtures containing the same level of halothane. Data for frequency of events on removal (fig. 5B) also illustrates that sevoflurane ameliorates the effect of halothane on suppression of SR Ca2+release, and the line again intercepts baseline conditions at approximately 0.1 mm halothane–0.5 mm sevoflurane.
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
×
Changes in Diastolic Ca2+
Halothane (0.6 mm) significantly (P  < 0.05) increased diastolic Ca2+throughout the exposure (figs. 1A and 6A), which returned to control levels on removal of halothane. In contrast, 0.6 mm sevoflurane significantly reduced diastolic Ca2+for a period of 120 s, after which diastolic Ca2+returned to control levels (figs. 2A and 6B). In cells pretreated with 1 μm ryanodine to inhibit SR function, no significant change in diastolic Ca2+occurred during exposure to halothane (n = 14) or sevoflurane (n = 12). Figure 6Cshows that 0.1 mm halothane also led to a sustained increase in diastolic Ca2+similar to that observed with 0.6 mm halothane. Application of a mixture of 0.1 mm halothane and 0.5 mm sevoflurane also produced a sustained increase in diastolic Ca2+; however, there was a 90-s delay before the increase in diastolic Ca2+reached significance.
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
×
Discussion
Halothane and Sevoflurane on Spontaneous Ca2+Release
These data describe the effects of halothane, isoflurane, and sevoflurane on the properties of spontaneous Ca2+release in isolated ventricular myocytes and the associated changes in diastolic Ca2+that accompany the application and removal of anesthetic, which help to further our understanding of the inotropic actions of these agents in ventricular muscle. One intriguing aspect of these data is that the effects of halothane on SR Ca2+regulation can be reversed by coapplication of sevoflurane.
During normal excitation–contraction coupling, Ca2+entry via  ICainduces the release of Ca2+from the SR via  the process of calcium-induced calcium release.25,26 However, in certain pathologic conditions (e.g.  , glycoside toxicity), cellular Ca2+overload occurs, which can result in arrhythmogenic activity. This results from spontaneous release of Ca2+from the SR, which induces delayed after depolarizations (via  inward Na+–Ca2+exchange current27 as Ca2+is extruded from the cell), potentially leading to the generation of spontaneous action potentials. The extent of spontaneous release of Ca2+from the SR is thought to be heavily influenced by the level of Ca2+within the lumen of the SR,28 and it has been proposed that luminal Ca2+modulates the sensitivity of the ryanodine receptor (RyR) to cytoplasmic Ca2+. In these studies, we have induced mild Ca2+overload to assess the impact of anesthetics on the sensitivity of the SR Ca2+release process.
Our data show that halothane induced an immediate release of SR Ca2+, which was ryanodine sensitive and consistent with sensitization of the Ca2+release process.3,4,7 In contrast, application of sevoflurane (although less potent than halothane in molar terms) initially inhibited SR Ca2+release. This result is similar to the decreased efficacy of SR Ca2+release in response to rapid cooling induced by sevoflurane.29 Coapplication of halothane and sevoflurane significantly ameliorated the sensitizing effect of halothane on the frequency of spontaneous SR Ca2+release, with the mixture of 0.1 mm halothane and 0.5 mm sevoflurane having little impact on the frequency or amplitude of SR Ca2+release, and effectively mimicked the results produced by 0.6 mm isoflurane.
On wash-off of halothane, spontaneous SR Ca2+release was inhibited, whereas removal of sevoflurane induced a burst of Ca2+release. As above, these effects of halothane were ameliorated by sevoflurane (figs. 4 and 5). Although these data do not permit a specific subcellular site to be identified, a plausible explanation of these results is that halothane and sevoflurane bind to the RyR, inducing either an increase7 or a decrease in its open probability, respectively. Their binding seems antagonistic because 0.5 mm sevoflurane blocked the effects of 0.1 mm halothane almost completely, but again, this may not reflect antagonism at the same site of action as halothane. These data also suggest that isoflurane seems to have no net effect on the RyR under these conditions.
The transient effects of halothane on the frequency of spontaneous Ca2+release are similar to those induced by a low dose of caffeine,24,30 which are thought to involve luminal feedback of RyR sensitivity. To explain data with halothane (and also caffeine),24,30 the initial increase in RyR opening would decrease SR Ca2+content (fig. 3). The reduction in SR luminal Ca2+would reduce RyR activation and therefore Ca2+efflux from the SR and a new steady state would be reached when Ca2+efflux was balanced by SR Ca2+uptake. On wash-off of halothane, the decrease in Ca2+release would result from a combination of lower SR Ca2+content and reduced RyR activity.24 
The effects of sevoflurane on the frequency of spontaneous Ca2+release are similar to those of tetracaine,24,31 which has been reported to decrease RyR open probability.31–33 To explain data with sevoflurane (and tetracaine),23,31 inhibition of SR Ca2+release would increase SR Ca2+content (fig. 3). The consequent increase of luminal Ca2+would overcome the sevoflurane-induced decrease in open probability of the RyR, and Ca2+efflux would increase. This would reach a new steady state when the enhanced efflux at the higher SR Ca2+was balanced by SR Ca2+uptake. On removal of sevoflurane, the burst of spontaneous Ca2+release would result from the restoration of RyR sensitivity coupled with the increased SR Ca2+content.
Changes in Diastolic Ca2+
Although the above-proposed mechanism is capable of explaining the effects of halothane and sevoflurane on the frequency of SR Ca2+release and SR Ca2+content, it can not explain fully the effects on diastolic Ca2+, because a mechanism centered around changes in the sensitivity of the RyR would be expected to induce only transient changes in diastolic Ca2+, as were observed with sevoflurane (and caffeine30). Halothane induced a ryanodine-sensitive maintained increase in diastolic Ca2+at doses between 0.1 and 0.6 mm, which suggests that additional mechanisms associated with the SR are affected. This could result from inhibition of SR Ca2+uptake by halothane,34 because other agents that inhibit SR Ca2+uptake35,36 also increase diastolic Ca2+. Figure 6Dillustrates that sevoflurane was able to delay the increase in diastolic Ca2+, suggesting that the effects of sevoflurane and halothane on diastolic Ca2+were additive rather than antagonistic.
Limitations and Summary
One limitation is that these data might overstate the importance of SR-dependent mechanisms in the inotropic profiles of the anesthetics studied as excitation-contraction coupling is heavily SR dependent in the rat. Second, the experiments were conducted at 30°C rather than 37°C—a strategy used to maximize fura-2 retention by cells to allow accurate and consistent measurement of fluorescence signals during long protocols, and the balance of Ca2+fluxes along the various pathways may differ slightly at 30°C compared with 37°C.
To summarize, these data suggest that halothane sensitizes, sevoflurane desensitizes, and isoflurane has no net effect on the SR Ca2+release process. Figure 7illustrates representative traces of cell shortening and the cytosolic fura-2 fluorescence ratio in an electrically stimulated cell exposed sequentially to halothane, then sevoflurane, and finally to a mixture of halothane and sevoflurane. Figures 7A and Bshow the characteristic inotropic profiles induced by halothane and sevoflurane as described in the introduction. Figure 7Cillustrates that the initial positive inotropic effect associated with halothane and the positive inotropic effect on removal of sevoflurane are both abolished when halothane and sevoflurane are applied simultaneously, corroborating the results of experiments conducted in spontaneously contracting cells. This illustrates the important contribution of anesthetic-induced changes in the sensitivity of the SR Ca2+release process to the inotropic profiles of these agents and further suggests that halothane and sevoflurane affect SR Ca2+release in an antagonistic manner such that the effects of halothane are ameliorated by sevoflurane.
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
×
References
Lynch C III, Vogel S, Sperelakis N: Halothane depression of myocardial slow action potentials. Anesthesiology 1981; 55:360–8Lynch, C Vogel, S Sperelakis, N
Luk HN, Lin CI, Chang CL, Lee AR: Differential inotropic effects of halothane and isoflurane in dog ventricular tissues. Eur J Pharm 1987; 136:409–13Luk, HN Lin, CI Chang, CL Lee, AR
Wheeler DM, Rice RT, Lakatta EG: The action of halothane on spontaneous contractile waves and stimulated contractions on isolated rat and dog heart cells. Anesthesiology 1990; 72:911–20Wheeler, DM Rice, RT Lakatta, EG
Harrison SM, Robinson M, Davies LA, Hopkins PM, Boyett MR: Mechanisms underlying the inotropic action of halothane on intact rat ventricular myocytes. Br J Anaesth 1999; 82:609–21Harrison, SM Robinson, M Davies, LA Hopkins, PM Boyett, MR
Davies LA, Hamilton DL, Hopkins PM, Boyett MR, Harrison SM: Concentration-dependent inotropic effects of halothane, isoflurane and sevoflurane on rat ventricular myocytes. Br J Anaesth 1999; 82:723–30Davies, LA Hamilton, DL Hopkins, PM Boyett, MR Harrison, SM
Davies LA, Gibson CN, Boyett MR, Hopkins PM, Harrison SM: Effects of isoflurane, sevoflurane, and halothane on myofilament Ca2+sensitivity and sarcoplasmic reticulum Ca2+release in rat ventricular myocytes. Anesthesiology 2000; 93:1034–44Davies, LA Gibson, CN Boyett, MR Hopkins, PM Harrison, SM
Connelly TJ, Coronado R: Activation of the Ca2+release channel of cardiac sarcoplasmic reticulum by volatile anesthetics. Anesthesiology 1994; 81:459–69Connelly, TJ Coronado, R
Lynch C III, Frazer MJ: Anesthetic alteration of ryanodine binding by cardiac calcium release channels. Biochim Biophys Acta 1994; 1194:109–17Lynch, C Frazer, MJ
Herland JS, Julian FJ, Stephenson DG: Halothane increases Ca2+efflux via  Ca2+channels of sarcoplasmic reticulum in chemically skinned rat myocardium. J Physiol 1990; 426:1–18Herland, JS Julian, FJ Stephenson, DG
Hannon JD, Cody MJ: Effects of volatile anesthetics on sarcolemmal calcium transport and sarcoplasmic reticulum calcium content in isolated myocytes. Anesthesiology 2002; 96:1457–64Hannon, JD Cody, MJ
Ikemoto Y, Yatani A, Arimura H, Yoshitake J: Reduction of the slow inward current of isolated rat ventricular cells by thiamylal and halothane. Acta Anaesthesiol Scand 1985; 29:583–6Ikemoto, Y Yatani, A Arimura, H Yoshitake, J
Bosnjak ZJ, Supan FD, Rusch NJ: The effects of halothane, enflurane, and isoflurane on calcium current in isolated canine ventricular cells. Anesthesiology 1991; 74:340–5Bosnjak, ZJ Supan, FD Rusch, NJ
Eskinder H, Rusch NJ, Supan FD, Kampine JP, Bosnjak ZJ: The effects of volatile anesthetics on L- and T-type calcium channel currents in canine Purkinje cells. Anesthesiology 1991; 74:919–26Eskinder, H Rusch, NJ Supan, FD Kampine, JP Bosnjak, ZJ
Pancrazio JJ: Halothane and isoflurane preferentially depress a slow inactivating component of Ca2+channel current in guinea-pig myocytes. J Physiol 1996; 494:94–103Pancrazio, JJ
Rithalia A, Hopkins PM, Harrison SM: The effects of halothane, isoflurane, and sevoflurane on Ca2+current and transient outward K+current in subendocardial and subepicardial myocytes from the rat left ventricle. Anesth Analg 2004; 99:1615–22Rithalia, A Hopkins, PM Harrison, SM
Hanley PJ, Loiselle DS: Mechanisms of force inhibition by halothane and isoflurane in intact rat cardiac muscle. J Physiol 1998; 506:231–44Hanley, PJ Loiselle, DS
Jiang YD, Julian FJ: Effects of halothane on [Ca2+]itransient, SR Ca2+content, and force in intact rat heart trabeculae. Am J Physiol 1998; 43:H106–14Jiang, YD Julian, FJ
Graham MD, Bru-Mercier G, Hopkins PM, Harrison SM: Transient and sustained changes in myofilament sensitivity to Ca2+contribute to the inotropic effects of sevoflurane in rat ventricle. Br J Anaesth 2005; 94:279–86Graham, MD Bru-Mercier, G Hopkins, PM Harrison, SM
Capogrossi MC, Stern MD, Spurgeon HA, Lakatta EG: Spontaneous Ca2+release from the sarcoplasmic reticulum limits Ca2+-dependent twitch potentiation in individual cardiac myocytes: A mechanism for maximum inotropy in the myocardium. J Gen Physiol 1988; 91:133–55Capogrossi, MC Stern, MD Spurgeon, HA Lakatta, EG
Diaz ME, Trafford AW, O’Neill SC, Eisner DA: Measurement of sarcoplasmic reticulum Ca2+content and sarcolemmal Ca2+fluxes in isolated rat ventricular myocytes during spontaneous Ca2+release. J Physiol 1997; 501:3–16Diaz, ME Trafford, AW O’Neill, SC Eisner, DA
Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, DC, National Academy Press, 1996Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council, Washington, DC National Academy Press
Cannell MB, Lederer WJ: A novel experimental chamber for single-cell voltage-clamp and patch-clamp applications with low electrical noise and excellent temperature and flow control. Pflugers Arch Eur J Physiol 1986; 406:536–9Cannell, MB Lederer, WJ
Franks NP, Lieb WR: Temperature dependence of the potency of volatile general anesthetics. Anesthesiology 1996; 84:716–20Franks, NP Lieb, WR
Lukyanenko V, Viatchenko-Karpinski S, Smirnov A, Wiesner TF, Gyorke S: Dynamic regulation of sarcoplasmic reticulum Ca2+content and release by luminal Ca2+-sensitive leak in rat ventricular myocytes. Biophys J 2001; 81:785–98Lukyanenko, V Viatchenko-Karpinski, S Smirnov, A Wiesner, TF Gyorke, S
Fabiato A: Time and calcium dependence of activation and inactivation of calcium-induced calcium release from the sarcoplasmic reticulum of a skinned cardiac Purkinje cell. J Gen Physiol 1985; 85:247–89Fabiato, A
Bers DM: Cardiac excitation-contraction coupling. Nature 2002; 415:198–205Bers, DM
Berlin JR, Cannell MB, Lederer WJ: Cellular origins of the transient inward current in cardiac myocytes: Role of fluctuations and waves of elevated intracellular calcium. Circ Res 1989; 65:115–26Berlin, JR Cannell, MB Lederer, WJ
Lukyanenko V, Subramanian S, Gyorke I, Wiesner TF, Gyorke S: The role of luminal Ca2+in the generation of Ca2+waves in rat ventricular myocytes. J Physiol 1999; 518:173–86Lukyanenko, V Subramanian, S Gyorke, I Wiesner, TF Gyorke, S
Park WK, Pancrazio JJ, Suh CK, Lynch C III: Myocardial depressant effects of sevoflurane: Mechanical and electrophysiologic actions in vitro  . Anesthesiology 1996; 84:1166–76Park, WK Pancrazio, JJ Suh, CK Lynch, C
O’Neill SC, Eisner DA: A mechanism for the effects of caffeine on Ca2+release during diastole and systole in isolated rat ventricular myocytes. J Physiol 1990; 430:519–36O’Neill, SC Eisner, DA
Overend CL, Eisner DA, O’Neill SC: The effect of tetracaine on spontaneous Ca2+release and sarcoplasmic reticulum calcium content in rat ventricular myocytes. J Physiol 1997; 502:471–9Overend, CL Eisner, DA O’Neill, SC
Xu L, Jones R, Meissner G: Effects of local anesthetics on single channel behavior of skeletal muscle calcium release channel. J Gen Physiol 1993; 101:207–33Xu, L Jones, R Meissner, G
Overend CL, O’Neill SC, Eisner DA: The effect of tetracaine on stimulated contractions, sarcoplasmic reticulum Ca2+content and membrane current in isolated rat ventricular myocytes. J Physiol 1998; 507:759–69Overend, CL O’Neill, SC Eisner, DA
Karon BS, Autry JM, Shi Y, Garnett CE, Inesi G, Jones LR, Kutchai H, Thomas DD: Different anesthetic sensitivities of skeletal and cardiac isoforms of the Ca-ATPase. Biochemistry 1999; 38:9301–7Karon, BS Autry, JM Shi, Y Garnett, CE Inesi, G Jones, LR Kutchai, H Thomas, DD
Kawai M, Hussain M, Orchard CH: Cs+inhibits spontaneous Ca2+release from sarcoplasmic reticulum of skinned cardiac myocytes. Am J Physiol 1998; 44:H422–30Kawai, M Hussain, M Orchard, CH
O’Neill SC, Miller L, Hinch R, Eisner DA: Interplay between SERCA and sarcolemmal Ca2+efflux pathways controls spontaneous release of Ca2+from the sarcoplasmic reticulum in rat ventricular myocytes. J Physiol 2004; 559:121–8O’Neill, SC Miller, L Hinch, R Eisner, DA
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 1. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm halothane. Mean data (± SEM, n = 13) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
×
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
Fig. 2. (  A  ) Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.6 mm sevoflurane. Mean data (± SEM, n = 10) describing the number (  B  ), amplitude (  C  ), and product of amplitude and frequency (  D  ) of spontaneous events per 30-s periods. Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  initial exposure (  columns 5  and  6  ). 
×
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
Fig. 3. (  A  ) Original trace of protocol for measurement of sarcoplasmic reticulum Ca2+content. Caffeine, 20 mm, was rapidly applied under control conditions at the time when the next spontaneous Ca2+release was expected. Caffeine was then removed, and control conditions were restored. Anesthetic was added, and the caffeine pulse was applied again at the start and end (not shown) of the anesthetic exposure and after removal of anesthetic (postcontrol, not shown). (  B  and  C  ) Mean data (± SEM) describing the peak caffeine-induced fura-2 fluorescence under control conditions and at the Start and End of a 4-min exposure to sevoflurane (  B  ) or halothane (  C  ). For Start data with sevoflurane (n = 10), caffeine was applied at the time when the first spontaneous transient was expected after the addition of the anesthetic, and for halothane (n = 9), caffeine was applied after the initial burst of Ca2+release. For End data, caffeine was applied at the end of the anesthetic exposure. *  P  < 0.05 to precontrol. +  P  < 0.05 to postcontrol. 
×
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
Fig. 4. Spontaneous Ca2+transients before, during, and after a 4-min exposure to 0.3 mm halothane plus 0.3 sevoflurane (  A  ) and 0.1 mm halothane plus 0.5 mm sevoflurane (  C  ). Mean data (± SEM) describing the number of spontaneous events per 30-s periods for 0.3 mm halothane plus 0.3 sevoflurane (  B  , n = 15) and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. 
×
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
Fig. 5. Composite curves for mixtures of halothane and sevoflurane (total anesthetic concentration of 0.6 mm) on the number of spontaneous Ca2+transients induced on initial exposure (  A  ) and upon removal of anesthetic(s) (  B  ).  Open symbols  identify data describing the effects of halothane–sevoflurane mixtures, and  filled symbols  identify concentrations of halothane alone. Data are mean ± SEM (n = 15 or 16). *  P  < 0.05 between halothane alone and halothane–sevoflurane mixtures.  Solid lines  are the result of linear regression of these data.  Dotted lines  represent the mean frequency of spontaneous release under baseline conditions. 
×
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
Fig. 6. Mean data (± SEM) describing diastolic fura-2 fluorescence ratio before, during, and after a 4-min exposure to 0.6 mm halothane (  A  , n = 13), 0.6 mm sevoflurane (  B  , n = 9), 0.1 mm halothane (  C  , n = 6), and 0.1 mm halothane plus 0.5 mm sevoflurane (  D  , n = 16). Control perfusate is shown as  gray bars  , and anesthetic exposure is shown as  white bars  . *  P  < 0.05 to three or more of the four 30-s precontrol periods. #  P  < 0.05 to two of the four precontrol periods and at least one postcontrol period. +  P  < 0.05  versus  steady state (  column 12  ). 
×
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
Fig. 7. Recordings of cell length and cytosolic fura-2 fluorescence ratio from a representative myocyte, stimulated electrically at 1 Hz (extracellular [Ca2+] of 1 mm), during sequential 1-min exposures to 0.6 mm halothane (  A  ), 0.6 mm sevoflurane (  B  ), and a mixture of 0.3 mm halothane and 0.3 mm sevoflurane (  C  ). Qualitatively similar results were seen in a total of 12 cells. 
×